<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
MRUS
Merus
$
()


  • JMP Securities healthcare analysts hold an analyst/industry conference call

    7/8/2024 - 12:36pm
  • Merus announces first patient dosed in Phase 2 trial of petosemtamab in 2L CRC

    7/8/2024 - 08:03am
  • Merus appoints Fabian Zohren as CMO

    7/1/2024 - 08:18am
  • Merus price target raised by $23 at Citi, here's why

    6/26/2024 - 06:38am
  • Xevinapant's discontinuation reads positive for Merus, says BofA

    6/25/2024 - 09:15am
  • Merus price target raised by $9 at Stifel, here's why

    6/17/2024 - 07:26am
  • Merus price target lowered by $4 at BofA, here's why

    6/5/2024 - 06:28am
  • Merus price target raised by $7 at BMO Capital, here's why

    6/4/2024 - 09:05am
  • Merus price target raised by $19 at Truist, here's why

    6/4/2024 - 08:08am
  • Merus price target raised by $13 at Canaccord, here's why

    6/4/2024 - 06:17am
  • Merus presents interim data on MCLA-145 monotherapy, combo with pembrolizumab

    6/2/2024 - 16:32pm
  • Merus 7.55M share Spot Secondary priced at $53.00

    5/29/2024 - 21:33pm
  • Merus price target raised by $19 at BofA, here's why

    5/29/2024 - 07:45am
  • Merus price target raised by $20 at H.C. Wainwright, here's why

    5/29/2024 - 06:05am
  • Merus price target raised by $12 at Citi, here's why

    5/28/2024 - 20:02pm
dynamic_feed Breaking News